| | By Kevin Dunleavy During a parliament hearing in Germany investigating Europe's vaccine supply negotiations with Pfizer, a company executive who participated in the talks emphatically denied that they were conducted by way of text message between Pfizer CEO Albert Bourla and EC President Ursula von der Leyen. |
|
|
|
By James Waldron When it comes to the current wave of layoffs, smaller biotechs have been disproportionately affected. But even some large drugmakers have been looking to lower their headcount, and now BioMarin is saying goodbye to 120 employees. |
By Kevin Dunleavy Amid a nationwide shortage of Adderall, add two more companies to the growing list of those that are having difficulty supplying the attention deficit hyperactivity disorder drug. Camber Pharmaceuticals and Sun Pharma are the latest to report supply problems. |
By Max Bayer Merck's sotatercept passed a critical phase 3 test for patients with pulmonary arterial hypertension, improving their distance in the six-minute walk test. The results have teed the company up to head to regulators and emphasize the lofty ambitions Merck has for the drug. |
By Max Bayer The CEO of the Biotech Innovation Organization, one of the top lobbying groups for the biopharma industry, is on leave amid internal dissent over her leadership, The Wall Street Journal reported. |
By Nick Paul Taylor Questions about an infusion device have scuttled Supernus Pharmaceuticals’ attempt to win approval of a Parkinson’s disease therapy. The complete response letter marks the second time in two years that the FDA has knocked back a filing for approval of the continuous treatment of motor fluctuations. |
By Zoey Becker Amid low demand for its latecomer COVID-19 vaccine, Novavax will pay Fujifilm up to $185 million in quarterly payments to end a supply deal. |
By Helen Floersh STING agonists have shown promise in preclinical research as mono- and adjunctive therapies, but they’ve faltered when it’s time to translate them to the clinic. Now, researchers have elucidated a mechanism that could explain why, as well as shown that a dual therapy might improve the drugs’ efficacy. |
By Jacqueline Renfrow In a series of unscripted videos, known as Coffee & Cords, patients share details about living with Dupuytren's contracture, a progressive hand condition that forms a collagen rope-like cord that pulls fingers toward the palm. Developed by Endo, the series is aimed at educating patients about the symptoms of the disease, plus treatment options for those with a diagnosis. |
By Conor Hale The project will explore whether applying AI to DNA and other omics sequencing data can increase their returns in successful biological targets and promising drug candidates. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we talk about our latest analysis on the world’s most productive biopharmas. We also discuss Biogen's tumultuous year and who it is considering for a new CEO. |
|
|---|
|
|
|
Wednesday, October 19th 2022 | 2:00 PM ET / 11:00 AM PT Products are being studied for multiple indications while also being developed in multiple presentations. Planning for success has now become multi-dimensional, and organizations must continue to stay launch ready. Register now. 
|
|
eBook Looking to implement a remote patient monitoring (RPM) program at your organization? Download the eBook from Health Catalyst to learn the essential components of successful RPM programs. Sponsored by: Health Catalyst |
eBook In this free guide, explore how Cloud Computing is enabling emerging biopharma organizations to decrease time-to-discovery in pursuit of breakthrough treatment modalities. Sponsored by: RCH Solutions |
Whitepaper Learn the benefits of unlocking data insights across the healthcare and life sciences ecosystem. Sponsored by: NTT DATA |
Whitepaper This paper is the first in a 4-part series focused on developing commercial models for gene therapies Sponsored by: Blue Matter, strategic consultants in the life sciences |
eBook With real-world data playing a significant role in health care decisions, life sciences leaders need to maximize their data investments. The best place to start is right here, with our e-book on the four steps to a more coordinated, connected real-world data strategy. Sponsored by: Optum |
Whitepaper SaaS LIMS from LabVantage Solutions Is Pre-Validated for Regulated Industries, Delivering Maximum Flexibility, Uptime, and Security. Sponsored by: LabVantage Solutions Inc. |
Whitepaper Advanced research requires advanced tools. The next-generation ELISA takes a fraction of the time to run eight analytes simultaneously while saving your sample volume. Sponsored by: Bio-Techne |
Whitepaper Supporting your product development programme through experience, expertise, and efficiency. Sponsored by: Almac Pharma Services |
Video Can an optimized research process--including AI-powered workflow and process automation tools--help get breakthrough drugs to market faster? Sponsored by: Proscia |
Video Learn how a centralized platform for pathology images, metadata, and analysis results can connect previously siloed research initiatives and advance our collective understanding of tissue. Sponsored by: Proscia |
Whitepaper What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent |
Research Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent |
Whitepaper How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
Whitepaper Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
Webinar Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics |
Custom Resource Center Read through this library of resources to find out how you can strengthen innovation and efficiency, improve safety and quality, and prioritize resources to support your long-term goals. Sponsored by: JLL |
Whitepaper Clarus Therapeutics (Clarus) is a men’s specialty pharmaceutical company that partnered with Catalent to develop a unique and convenient drug delivery form for their hormone replacement therapy. Sponsored by: Catalent |
Whitepaper Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Catalent |
Whitepaper Explore how Thermo Scientific’s Process Liquid Preparation Services can help you plan for scalable buffer preparation. Sponsored by: Thermo Fisher Scientific |
| |
|
